Browse Arkansas Code titles and sections
38 U.S.C. § 7309A — Office of Patient Advocacy
Federal law — U.S. Code and appendices · legal_authorities
**(a) Establishment.—** There is established in the Department within the Office of the Under Secretary for Health an office to be known as the “Office of Patient Advocacy” (in this section referred to as the “Office”).
**(b) Head.—**
(1) The Director of the Office of Patient Advocacy shall be the head of the Office.
(2) The Director of the Office of Patient Advocacy shall be appointed by the Under Secretary for Health from among individuals qualified to perform the duties of the position and shall report directly to the Under Secretary for Health.
**(c) Function.—**
(1) The function of the Office is to carry out the Patient Advocacy Program of the Department.
(2) In carrying out the Patient Advocacy Program of the Department, the Director shall ensure that patient advocates of the Department—
(A) advocate on behalf of veterans with respect to health care received and sought by veterans under the laws administered by the Secretary;
(B) carry out the responsibilities specified in subsection (d); and
(C) receive training in patient advocacy.
(3) Beginning not later than 18 months after the date of the enactment of this paragraph, the Director shall establish an information technology system that will allow a veteran (or the designated representative of a veteran) to electronically—
(A) file a complaint that will be received by the appropriate patient advocate; and
(B) at any time view the status of the complaint, including interim and final actions that have been taken to address the complaint.
**(d) Patient Advocacy Responsibilities.—** The responsibilities of each patient advocate at a medical facility of the Department are the following:
(1) To resolve complaints by veterans with respect to health care furnished under the laws administered by th
Source: Supplied U.S. Code snapshot — release unconfirmed · 38 U.S.C. § 7309A
Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 9150513e8bdcbef136f48973310c89b0bfb2f81214794aeabfc2fa0c88be8343. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:record_usc_8fc6b61c08fd1806d6cc1bc9
Source file: Laws/federal/codes/united-states-code/title-38/section-7309a-office-of-patient-advocacy--5a84c26538.md
Pages: Not recorded – Not recorded
Passage SHA-256: 492159964c3d2378c1844bba934bd562ebe3722bc1433028dd55a56033fd918f
Source location: Title 38, Chapter 73, § 7309A; chapter-073-veterans-health-administration-organization-and-functions.md
Stored source content
**(a) Establishment.—** There is established in the Department within the Office of the Under Secretary for Health an office to be known as the “Office of Patient Advocacy” (in this section referred to as the “Office”).
**(b) Head.—**
(1) The Director of the Office of Patient Advocacy shall be the head of the Office.
(2) The Director of the Office of Patient Advocacy shall be appointed by the Under Secretary for Health from among individuals qualified to perform the duties of the position and shall report directly to the Under Secretary for Health.
**(c) Function.—**
(1) The function of the Office is to carry out the Patient Advocacy Program of the Department.
(2) In carrying out the Patient Advocacy Program of the Department, the Director shall ensure that patient advocates of the Department—
(A) advocate on behalf of veterans with respect to health care received and sought by veterans under the laws administered by the Secretary;
(B) carry out the responsibilities specified in subsection (d); and
(C) receive training in patient advocacy.
(3) Beginning not later than 18 months after the date of the enactment of this paragraph, the Director shall establish an information technology system that will allow a veteran (or the designated representative of a veteran) to electronically—
(A) file a complaint that will be received by the appropriate patient advocate; and
(B) at any time view the status of the complaint, including interim and final actions that have been taken to address the complaint.
**(d) Patient Advocacy Responsibilities.—** The responsibilities of each patient advocate at a medical facility of the Department are the following:
(1) To resolve complaints by veterans with respect to health care furnished under the laws administered by the Secretary that cannot be resolved at the point of service or at a higher level easily accessible to the veteran.
(2) To present at various meetings and to various committees the issues experienced by veterans in receiving such health care at such medical facility.
(3) To express to veterans their rights and responsibilities as patients in receiving such health care.
(4) To manage the Patient Advocate Tracking System of the Department at such medical facility.
(5) To compile data at such medical facility of complaints made by veterans with respect to the receipt of such health care at such medical facility and the satisfaction of veterans with such health care at such medical facility to determine whether there are trends in such data.
(6) To ensure that a process is in place for the distribution of the data compiled under paragraph (5) to appropriate leaders, committees, services, and staff of the Department.
(7) To identify, not less frequently than quarterly, opportunities for improvements in the furnishing of such health care to veterans at such medical facility based on complaints by veterans.
(8) To ensure that any significant complaint by a veteran with respect to such health care is brought to the attention of appropriate staff of the Department to trigger an assessment of whether there needs to be a further analysis of the problem at the facility-wide level.
(9) To support any patient advocacy programs carried out by the Department.
(10) To ensure that all appeals and final decisions with respect to the receipt of such health care are entered into the Patient Advocate Tracking System of the Department.
(11) To understand all laws, directives, and other rules with respect to the rights and responsibilities of veterans in receiving such health care, including the appeals processes available to veterans.
(12) To ensure that veterans receiving mental health care, or the surrogate decision-makers for such veterans, are aware of the rights of veterans to seek representation from systems established under section 103 of the Protection and Advocacy for Mentally Ill Individuals Act of 1986 11 See References in Text note below. ([42 U.S.C. 10803](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section10803&num=0&edition=prelim)) to protect and advocate the rights of individuals with mental illness and to investigate incidents of abuse and neglect of such individuals.
(13) To fulfill requirements established by the Secretary with respect to the inspection of controlled substances.
(14) To document potentially threatening behavior and report such behavior to appropriate authorities.
**(e) Training.—** In providing training to patient advocates under subsection (c)(2)(C), the Director shall ensure that such training is consistent throughout the Department.
**(f) Controlled Substance Defined.—** In this section, the term “controlled substance” has the meaning given that term in section 102 of the Controlled Substances Act ([21 U.S.C. 802](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section802&num=0&edition=prelim)).
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
The Secretary shall make allotments under this subchapter to eligible systems to establish and administer systems—
(1) which meet the requirements of [section 10805 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section10805&num=0&edition=prelim); and
(2) which are designed to—
(A) protect and advocate the rights of individuals with mental illness; and
(B) investigate incidents of abuse and neglect of individuals with mental illness if the incidents are reported to the system or if there is probable cause to believe that the incidents occurred.
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 10803
Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
As used in this subchapter:
(1) The term “addict” means any individual who habitually uses any narcotic drug so as to endanger the public morals, health, safety, or welfare, or who is so far addicted to the use of narcotic drugs as to have lost the power of self-control with reference to his addiction.
(2) The term “administer” refers to the direct application of a controlled substance to the body of a patient or research subject by—
(A) a practitioner (or, in his presence, by his authorized agent), or
(B) the patient or research subject at the direction and in the presence of the practitioner,
whether such application be by injection, inhalation, ingestion, or any other means.
(3) The term “agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser; except that such term does not include a common or contract carrier, public warehouseman, or employee of the carrier or warehouseman, when acting in the usual and lawful course of the carrier’s or warehouseman’s business.
(4) The term “Drug Enforcement Administration” means the Drug Enforcement Administration in the Department of Justice.
(5) The term “control” means to add a drug or other substance, or immediate precursor, to a schedule under part B of this subchapter, whether by transfer from another schedule or otherwise.
(6) The term “controlled substance” means a drug or other substance, or immediate precursor, included in schedule I, II, III, IV, or V of part B of this subchapter. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are defined or used in subtitle E of the Internal Revenue Code of 1986.
(7) The term “counterfeit substance” means a controlled substance which, or the container or labelin
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 802
Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
Page 782
TITLE 21—FOOD AND DRUGS
§ 801a
ing it into counterfeit opioid pills. Because fentanyl is
lethal in even miniscule doses, this is an extremely
deadly tactic, as it too often causes users to ingest a
fatal amount unknowingly.
SEC. 2. Agency Action. The Secretary of Health and
Human Services shall, consistent with section 319 of
the Public Health Service Act, 42 U.S.C. 247d, consider
declaring that the drug demand and opioid crisis de-
scribed in section 1 of this memorandum constitutes a
Public Health Emergency. Additionally, the heads of
executive departments and agencies, as appropriate and
consistent with law, shall exercise all appropriate
emergency authorities, as well as other relevant au-
thorities, to reduce the number of deaths and minimize
the devastation the drug demand and opioid crisis in-
flicts upon American communities.
SEC. 3. General Provisions. (a) Nothing in this memo-
randum shall be construed to impair or otherwise af-
fect:
(i) the authority granted by law to an executive de-
partment or agency, or the head thereof; or
(ii) the functions of the Director of the Office of Man-
agement and Budget relating to budgetary, administra-
tive, or legislative proposals.
(b) This memorandum shall be implemented con-
sistent with applicable law and subject to the avail-
ability of appropriations.
(c) This memorandum is not intended to, and does
not, create any right or benefit, substantive or proce-
dural, enforceable at law or in equity by any party
against the United States, its departments, agencies, or
entities, its officers, employees, or agents, or any other
person.
(d) The Secretary of Health and Human Services is
hereby authorized and directed to publish this memo-
randum in the Federal Register.
DONALD J. TRUMP.
§ 801a
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 802
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 802. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 1169
TITLE 38—VETERANS’ BENEFITS
§ 7309A
1 See References in Text note below.
‘‘(F) The term ‘veteran’ means an individual who
served in the Armed Forces, including an individual
who served in a reserve component of the Armed
Forces, and who was discharged or released there-
from, regardless of the conditions of such discharge
or release.
‘‘(g) DEFINITION OF VET CENTER.—In this section, the
term ‘Vet Center’ has the meaning given that term in
section 1712A(h) of title 38, United States Code.’’
§ 7309A. Office of Patient Advocacy
(a) ESTABLISHMENT.—There is established in
the Department within the Office of the Under
Secretary for Health an office to be known as
the ‘‘Office of Patient Advocacy’’ (in this sec-
tion referred to as the ‘‘Office’’).
(b) HEAD.—(1) The Director of the Office of Pa-
tient Advocacy shall be the head of the Office.
(2) The Director of the Office of Patient Advo-
cacy shall be appointed by the Under Secretary
for Health from among individuals qualified to
perform the duties of the position and shall re-
port directly to the Under Secretary for Health.
(c) FUNCTION.—(1) The function of the Office is
to carry out the Patient Advocacy Program of
the Department.
(2) In carrying out the Patient Advocacy Pro-
gram of the Department, the Director shall en-
sure that patient advocates of the Department—
(A) advocate on behalf of veterans with re-
spect to health care received and sought by
veterans under the laws administered by the
Secretary;
(B) carry out the responsibilities specified in
subsection (d); and
(C) receive training in patient advocacy.
(3) Beginning not later than 18 months after
the date of the enactment of this paragraph, the
Director shall establish an information tech-
nology system that will allow a v
Source: Supplied 2024 U.S. Code historical extraction · 38 U.S.C. § 7309A
Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.
Federal law — U.S. Code and appendices · legal_authorities
Page 8084
TITLE 42—THE PUBLIC HEALTH AND WELFARE
§ 10803
1 So in original. The comma probably should not appear.
2 See References in Text note below.
106–402, Oct. 30, 2000, 114 Stat. 1677. Subtitle C of the Act
probably means subtitle C of title I of the Act, which
is classified generally to part C (§ 15041 et seq.) of sub-
chapter I of chapter 144 of this title. For complete clas-
sification of this Act to the Code, see Short Title note
set out under section 15001 of this title and Tables.
The Developmental Disabilities Assistance and Bill of
Rights Act, referred to in par. (8), is title I of Pub. L.
88–164, as added by Pub. L. 98–527, § 2, Oct. 19, 1984, 98
Stat. 2662, which was repealed by Pub. L. 106–402, title
IV, § 401(a), Oct. 30, 2000, 114 Stat. 1737. Part C of the Act
was classified generally to subchapter III (§ 6041 et seq.)
of chapter 75 of this title. Provisions similar to former
part C of the Act are contained in subtitle C of title I
of the Developmental Disabilities Assistance and Bill
of Rights Act of 2000, Pub. L. 106–402, which is classified
generally to part C (§ 15041 et seq.) of subchapter I of
chapter 144 of this title.
AMENDMENTS
2000—Par. (2). Pub. L. 106–402 substituted ‘‘subtitle C
of the Developmental Disabilities Assistance and Bill
of Rights Act of 2000’’ for ‘‘part C of the Developmental
Disabilities Assistance and Bill of Rights Act’’.
Par. (4). Pub. L. 106–310, § 3206(b)(1)(A), inserted
‘‘, except as provided in section 10804(d) of this title,’’
after ‘‘means’’ in introductory provisions.
Par. (4)(B). Pub. L. 106–310, § 3206(b)(1)(B), designated
existing provisions as cl. (i), redesignated former cls. (i)
to (iii) as subcls. (I) to (III), respectively, of cl. (i), and
added cl. (ii).
Par. (8). Pub. L. 106–3
Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 10803
Stored review status: historical_2024_not_currentness_verified. The source passage cites 42 U.S.C. § 10803. This identifies an authority to review, not proof of applicability.